Last reviewed · How we verify
NCT03368794: N-TREE
Naloxone to TReatment Entry in the Emergency Setting
NA trial testing Active treatment referral of opioid overdose survivors to long-term treatment in Opioid Dependence. Withdrawn.
12 March 2021
Quick facts
| Lead sponsor | Anders C Håkansson |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Start date | 15 September 2017 |
| Primary completion | 12 March 2021 |
| Estimated completion | 12 March 2021 |
| Sites | 1 location across Sweden |
Drugs / interventions tested
- Active treatment referral of opioid overdose survivors to long-term treatment
- Control
Conditions studied
- Opioid Dependence — all drugs for Opioid Dependence →
- Opioid Intoxication — all drugs for Opioid Intoxication →
- Substance Use Disorders — all drugs for Substance Use Disorders →
Sponsor
Anders C Håkansson
Who can join
18 and older, any sex, with Opioid Dependence or Opioid Intoxication. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study tests a structured referral process for opioid overdose survivors, from pre-hospital emergency care to long-term treatment of the individual's substance use-related disorder.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03368794
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Opioid Dependence
Currently open trials in the same condition.
- NCT05585229 — Standardized Natural Psilocybin-assisted Psychotherapy for Tapering of Opioid Medication · Phase 2 · recruiting
- NCT06574009 — Better Options for Chronic Cancer Pain · Phase 4 · recruiting
- NCT06837662 — The MOUD Plus Pilot: Counseling and Peer Support to Support Retention for Medically Complex Patients With Opioid Use Dis · NA · recruiting
- NCT05620940 — A Clinical Trial to Assess Pharmacokinetic Profiles, Safety and Tolerability of IVL3004 and IVL4002 in Healthy Male Subj · Phase 1 · recruiting
- NCT05603702 — STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis · Phase 1 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03368794 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Anders C Håkansson
- Last refreshed: 16 March 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03368794.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing